Clinical Trials on Pulmonary Thromboembolisms

Total 9074 results

China-Japan Friendship Hospital

Recruiting

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Quality Improvement | Venous Thromboembolic Disease

China
McMaster University
Heart and Stroke Foundation of Ontario

Completed

Fixed Dose Heparin Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada, New Zealand
University Hospital, Brest

Not yet recruiting

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT) (PRONOSPECT)

Venous Thromboembolism | Pulmonary Embolism

France
Central Hospital, Nancy, France
Ministry of Health, France; University Hospital of Saint-Etienne; Grand Est Region

Completed

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 (COVI-DOSE)

Thrombosis | Deep Vein Thrombosis | COVID | Pulmonary Embolism

France
Instituto Mexicano del Seguro Social

Completed

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding | Venous Thromboses

Mexico
University of Utah

Completed

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Ottawa Hospital Research Institute
The Ottawa Hospital Academic Medical Association

Withdrawn

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep-Vein Thrombosis

Canada
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Deep Vein Thrombosis | Pulmonary Embolism

Italy
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
University of Utah
Stanford University

Completed

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus | Reconstructive Surgery

United States
University of Michigan
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

Atrial Fibrillation | Venous Thromboembolism | Pulmonary Embolism

United States
Bayer
Janssen Research & Development, LLC

Withdrawn

Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm (VeriXAPPORT)

Atrial Fibrillation | Venous Thromboembolism | Pulmonary Embolism
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton

Unknown

Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) (ROCITP2)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada
Drahomir Aujesky
Bayer; The Ottawa Hospital; University of Bern; Leiden University Medical Center; Schweizerischer Nationalfonds

Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism (SAFE-SSPE)

Cardiovascular Diseases | Respiratory Tract Diseases | Lung Diseases | Embolism | Embolism and Thrombosis | Bleeding | Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

Netherlands, Switzerland, Belgium, France, Canada
BiO2 Medical

Terminated

Angel® Catheter Early Feasibility Clinical Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Bleeding as Surgical Complication (Treatment)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Italian Federation of Anticoagulation Clinics (FCSA)

Completed

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Deep Vein Thrombosis | Pulmonary Embolism

Italy
University Of Perugia

Unknown

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Atherosclerosis | Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Italy, Austria
Brigham and Women's Hospital

Active, not recruiting

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
McMaster University

Completed

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Lung Neoplasms | Venous Thromboembolism | Pulmonary Embolism

Canada
BiO2 Medical
Novella Clinical; CardioMed Device Consultants, LLC; Intrinsic Imaging, LLC

Completed

The Angel® Catheter Pivotal Clinical Trial

Trauma | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Leiden University Medical Center

Recruiting

Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Venous Thromboses

Netherlands
Bayer

Withdrawn

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement) (XYRIS)

Total Hip Replacement | Total Knee Replacement | Prophylaxis, Thromboembolism, Venous
Fundación Pública Andaluza para la gestión de la...

Unknown

Study on the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism (TEP-RR)

Pulmonary Embolism

Spain
Northwell Health

Completed

A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients

Venous Thromboembolism | Arterial Thromboembolism

United States
University Hospital, Angers

Not yet recruiting

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing (RIVACAST)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis | Lower Limb Trauma | Immobilisation

France
University Hospital, Brest

Recruiting

Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) (THROMPET)

Venous Thromboembolism (VTE)

France
Ege University

Recruiting

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Pulmonary Embolism

Turkey
Hospital Universitari Vall d'Hebron Research Institute

Completed

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

COVID-19 | Critical Illness | Venous Thromboembolism | SARS-CoV Infection | Pulmonary Embolism | Sars-CoV2 | Venous Thromboses | Pulmonary Embolism and Thrombosis | Venous Thromboses, Deep | Venous Thrombosis Pulmonary

Spain
University of Arizona

Recruiting

Risk Factors for Thrombosis in Children With Central Venous Lines

Pediatric Venous Thromboembolism

United States
University Hospital, Angers

Recruiting

Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilisation (CCASTING)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis | Lower Limb Trauma | Immobilisation Syndrome

France
National Taiwan University Hospital

Unknown

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Deep Venous Thromboembolism

Taiwan
University of Gaziantep

Completed

Obstructive Sleep Apnea in Pulmonary Embolism

Obstructive Sleep Apnea | Pulmonary Thromboembolism

Turkey
Taipei Medical University WanFang Hospital

Completed

Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation

Aortic Dissection | Pulmonary Thromboembolism | May-Thurner Syndrome | Thrombosis in Left Atrium and Right Axillary Artery | Double IVC

Taiwan
University of Maryland, Baltimore

Terminated

CT for Pulmonary Thromboembolic Disease (CT for PE)

Pulmonary Embolism

United States
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Ontario

Completed

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism (REMARK)

Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep-Vein Thrombosis

Canada
Bayer

Completed

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Treatment of Venous Thromboembolism

Japan
Azidus Brasil

Unknown

Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Prevention of Venous Thromboembolism

Brazil
Ya-Wei Xu
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern...

Recruiting

Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism

Venous Thromboembolism (VTE)

China
Bristol-Myers Squibb

Completed

A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

Venous Thromboembolism (VTE)

United States
Poznan University of Medical Sciences

Recruiting

Catheter-directed Thrombectomy in High and Intermediate-high Risk Pulmonary Embolism (CATH-PE)

Pulmonary Embolism With Acute Cor Pulmonale

Poland
Bristol-Myers Squibb

Completed

A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot

Venous Thromboembolism (VTE)

United States
Ottawa Hospital Research Institute
BioMérieux; Centre Hospitalier Régional et Universitaire de Brest

Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism (REVERSEII)

Idiopathic Venous Thromboembolism

United States, Canada, Australia, Belgium, France, India, Switzerland
Poznan University of Medical Sciences
Polish Cardiac Society

Recruiting

Polish Multicenter PERTs PE Outcomes Registry (PolPERTs)

Pulmonary Embolism With Acute Cor Pulmonale

Poland
Fadoi Foundation, Italy

Completed

Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients (RICO)

Prevention of Venous Thromboembolism

Italy
Fadoi Foundation, Italy
University Of Perugia

Completed

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. (PRO-LAPSII)

Prevention of Venous Thromboembolism

Italy
Azidus Brasil

Unknown

Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Prevention of Venous Thromboembolism

Brazil
Victor Tapson, MD
Bristol-Myers Squibb

Terminated

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism (SAFE-LYSE)

Pulmonary Embolism | Right Ventricular Dysfunction | Right Ventricular Failure | Pulmonary Embolism With Acute Cor Pulmonale | Pulmonary Embolism With Pulmonary Infarction | Pulmonary Embolism Subacute Massive

United States
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Treatment of Venous Thromboembolism in Cancer Patients

Sweden
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Treatment of Venous Thromboembolism in Cancer Patients

United Kingdom

Clinical Trials on Pulmonary Thromboembolisms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations